elemento de sela e estrutura de misturador estático
The invention relates to targeted binding agents against α5 1 and uses of such agents. More specifically, the invention relates to fully human monoclonal antibodies directed to α5 1. The described targeted binding agents are useful in the treatment of diseases associated with the activity and/or ove...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Patent |
| Sprache: | por |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | The invention relates to targeted binding agents against α5 1 and uses of such agents. More specifically, the invention relates to fully human monoclonal antibodies directed to α5 1. The described targeted binding agents are useful in the treatment of diseases associated with the activity and/or overproduction of α5 1 and as diagnostics. |
|---|